ID
39644
Description
Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.; ODM derived from: https://clinicaltrials.gov/show/NCT01565889
Lien
https://clinicaltrials.gov/show/NCT01565889
Mots-clés
Versions (1)
- 07/02/2020 07/02/2020 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
7 février 2020
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Hepatitis C NCT01565889
Eligibility Hepatitis C NCT01565889
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Liver Cirrhosis | Liver Cirrhosis Suspected
Type de données
boolean
Alias
- UMLS CUI [1]
- C0023890
- UMLS CUI [2,1]
- C0023890
- UMLS CUI [2,2]
- C0750491
Description
Chronic liver disease Other
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0341439
- UMLS CUI [1,2]
- C0205394
Description
Medical History Consistent with Decompensated liver disease
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0262926
- UMLS CUI [1,2]
- C0332290
- UMLS CUI [1,3]
- C4075847
Description
Illicit medication use
Type de données
boolean
Alias
- UMLS CUI [1]
- C0281875
Description
Pregnancy | Breast Feeding | Gender Partner Pregnancy
Type de données
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
- UMLS CUI [3,1]
- C0079399
- UMLS CUI [3,2]
- C0682323
- UMLS CUI [3,3]
- C0032961
Description
Medical contraindication PEGINTERFERON Therapy | Medical contraindication Ribavirin Therapy
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0982327
- UMLS CUI [1,3]
- C0087111
- UMLS CUI [2,1]
- C1301624
- UMLS CUI [2,2]
- C0035525
- UMLS CUI [2,3]
- C0087111
Description
Substance Use Disorders
Type de données
boolean
Alias
- UMLS CUI [1]
- C0038586
Similar models
Eligibility Hepatitis C NCT01565889
- StudyEvent: Eligibility
C0262926 (UMLS CUI [1,2])
C3898900 (UMLS CUI [2,1])
C0031809 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0019196 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0019693 (UMLS CUI [4,2])
C0205191 (UMLS CUI [1,2])
C1963724 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0877598 (UMLS CUI [2])
C1265611 (UMLS CUI [1,2])
C0524910 (UMLS CUI [1,2])
C0023890 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0205394 (UMLS CUI [1,2])
C0332290 (UMLS CUI [1,2])
C4075847 (UMLS CUI [1,3])
C0006147 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0682323 (UMLS CUI [3,2])
C0032961 (UMLS CUI [3,3])
C0982327 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C1301624 (UMLS CUI [2,1])
C0035525 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])